Gossamer Bio Announces $212 Million Private Placement Financ

- In Conjunction with Offering, Interim TORREY OLE Data and PROSERA Phase 3 Design Disclosed via 8-K; Conference Call to Discuss Data and Phase 3 Design with Leading PAH KOLs to be Held on July 25th...

Related Keywords

United States , Faheem Hasnain , Wedbush Pacgrow , Ray Benza , Piper Sandler , Jim White , Seralutinib Program Update Call , International Number , Exchange Commission , Hc Wainwright Co , Nasdaq , Gossamer Bio Inc , Enterprise Associates , Gossamer Bio , New Enterprise Associates , Armistice Capital , Madison Avenue Partners , Samsara Biocapital , Silverarc Capital , Octagon Capital , Boxer Capital , Federated Hermes Kaufmann Funds , Palo Alto Investors , Rock Springs Capital , Ardi Ghofrani , Dial In Number , Securities Act , Private Securities Litigation Reform Act , Markets ,